Article Details
Retrieved on: 2023-01-07 17:10:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer's shares are attractively valued in the market right now. The company should score plenty of key approvals this year.
Article found on: www.fool.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here